drugset / Trial / NCT03439709

Multicenter Evaluation of the Effect of Upfront Radiosurgery on Residual Growth Hormone-secreting Pituitary Adenoma

NCT03439709

Phase 3 Unknown 90 enrolled Samsung Medical Center
RandomizedParallel-groupOpen-labelTreatment

Summary

In this study, the investigators hypothesize that upfront gamma knife radiosurgery with drug therapy is superior in the treatment of growth hormone-secreting pituitary tumors after primary surgical treatment compared with the drug therapy alone. This study can provide useful clinical information in the treatment of patients with acromegaly.

Timeline

Start
2018-03-01
Primary completion
2022-06-30
Completion
2022-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Lanreotide Other / unclassified 60 mg